Skip to main content
Top
Published in: Abdominal Radiology 3/2011

01-06-2011

Management of local recurrence of colorectal cancer: the role of PET/CT

Authors: Yoshiko Bamba, Michio Itabashi, Shingo Kameoka

Published in: Abdominal Radiology | Issue 3/2011

Login to get access

Abstract

Aim

The aim was to examine the clinical applicability of positron-emission tomography/computed tomography (PET/CT) for diagnosing local recurrence of colorectal cancer.

Methods

From August 2003 to August 2008, 256 patients with colorectal cancer underwent PET/CT scanning for staging or restaging. Local recurrence was detected in 22 patients (18 men, 4 women) postsurgically.

Results

Of the 22 patients, 21 (95.5%) underwent positive 2-[fluorine-18]-fluoro-2-deoxy-d-glucose uptake and were diagnosed with local recurrence by PET/CT; the results were negative in one case (4.5%). The sensitivity, specificity, positive predictive value, and negative predictive value for local recurrence were 95.5%, 100%, 100%, and 99.6%, respectively. CT/MRI scans yielded the following results: positive, 10 cases (45.5%); suspected positive, 11 cases (50.0%); negative, 1 case (4.5%). In the suspected positive cases, not only imaging but also colonoscopy and tumor markers among other techniques were used for definitive diagnosis.

Conclusion

PET/CT has high sensitivity and specificity for diagnosing local recurrence of colorectal cancer and would be useful especially in the case of locally recurrent colorectal cancer suspected to be positive by CT/MRI.
Literature
1.
go back to reference Watson AJ, Lolohea S, Robertson GM, Frizelle FA (2007) The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 50:102–114PubMedCrossRef Watson AJ, Lolohea S, Robertson GM, Frizelle FA (2007) The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 50:102–114PubMedCrossRef
2.
go back to reference Schaefer O, Langer M (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 17:2044–2054PubMedCrossRef Schaefer O, Langer M (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 17:2044–2054PubMedCrossRef
3.
go back to reference Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM (2009) Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol 64:225–237PubMedCrossRef Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM (2009) Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol 64:225–237PubMedCrossRef
4.
go back to reference Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822PubMedCrossRef Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822PubMedCrossRef
5.
go back to reference Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA (1998) Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227:319–323PubMedCrossRef Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA (1998) Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227:319–323PubMedCrossRef
6.
go back to reference Veit P, Kuhle C, Beyer T, et al. (2006) Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated pet/ct colonography: technical feasibility and first experiences in patients with colorectal cancer. Gut 55:68–73PubMedCrossRef Veit P, Kuhle C, Beyer T, et al. (2006) Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated pet/ct colonography: technical feasibility and first experiences in patients with colorectal cancer. Gut 55:68–73PubMedCrossRef
7.
go back to reference Scott AM, Gunawardana DH, Kelley B, et al. (2008) PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J Nucl Med 49:1451–1457PubMedCrossRef Scott AM, Gunawardana DH, Kelley B, et al. (2008) PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J Nucl Med 49:1451–1457PubMedCrossRef
8.
go back to reference Vikram R, Iyer RB (2008) PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 8(Suppl A):S46–S51PubMedCrossRef Vikram R, Iyer RB (2008) PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 8(Suppl A):S46–S51PubMedCrossRef
9.
go back to reference Potter KC, Husband JE, Houghton SL, Thomas K, Brown G (2009) Diagnostic accuracy of serial ct/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 52:253–259PubMedCrossRef Potter KC, Husband JE, Houghton SL, Thomas K, Brown G (2009) Diagnostic accuracy of serial ct/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 52:253–259PubMedCrossRef
10.
go back to reference Winton E, Heriot AG, Ng M, et al. (2009) The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 100:693–700PubMedCrossRef Winton E, Heriot AG, Ng M, et al. (2009) The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 100:693–700PubMedCrossRef
11.
go back to reference Zhang C, Chen Y, Xue H, et al. (2009) Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 124:167–173PubMedCrossRef Zhang C, Chen Y, Xue H, et al. (2009) Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 124:167–173PubMedCrossRef
Metadata
Title
Management of local recurrence of colorectal cancer: the role of PET/CT
Authors
Yoshiko Bamba
Michio Itabashi
Shingo Kameoka
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2011
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-010-9639-z

Other articles of this Issue 3/2011

Abdominal Radiology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.